B.M.P. PHARMA TRAD (BMP.SG) Working Capital to Net Assets Ratio
B.M.P. PHARMA TRAD (BMP.SG) working capital to net assets ratio. B.M.P. PHARMA TRAD (BMP.SG) (BMP) has a Working Capital to Net Assets ratio of 86.3% as of December 2025. Working capital of €7.68 Million (current assets of €8.09 Million minus current liabilities of €411.21K) is measured against net assets of €8.90 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of B.M.P. PHARMA TRAD (BMP.SG) to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of B.M.P. PHARMA TRAD (BMP.SG) (2013–2025)
Working capital to net assets ratio of B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2025. This chart shows how B.M.P. PHARMA TRAD (BMP.SG)'s Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 86.3%, reflecting working capital of €7.68 Million against net assets of €8.90 Million EUR. See how many days can B.M.P. PHARMA TRAD (BMP.SG) fund operations to measure how many days the company can operate on defensive assets alone.
B.M.P. PHARMA TRAD (BMP.SG) Working Capital to Net Assets Ratio by Year (2013–2025)
B.M.P. PHARMA TRAD (BMP.SG) working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of B.M.P. PHARMA TRAD (BMP.SG).
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 86.3% | €7.68 Million | €8.90 Million | €8.09 Million | €411.21K | ▼ -6.5 pp |
| 2024 | 92.8% | €8.30 Million | €8.94 Million | €8.45 Million | €158.06K | ▲ +13.9 pp |
| 2023 | 78.9% | €6.85 Million | €8.68 Million | €7.14 Million | €292.64K | ▲ +12.4 pp |
| 2022 | 66.5% | €6.78 Million | €10.18 Million | €7.31 Million | €539.93K | ▲ +16.4 pp |
| 2021 | 50.1% | €4.32 Million | €8.61 Million | €4.85 Million | €532.67K | ▲ +28.5 pp |
| 2020 | 21.6% | €1.32 Million | €6.10 Million | €1.95 Million | €634.00K | ▼ -16.3 pp |
| 2019 | 37.9% | €2.25 Million | €5.93 Million | €2.53 Million | €284.69K | ▲ +4.0 pp |
| 2018 | 33.9% | €1.91 Million | €5.62 Million | €2.18 Million | €276.47K | ▲ +5.1 pp |
| 2017 | 28.8% | €1.49 Million | €5.16 Million | €1.73 Million | €242.84K | ▼ -0.3 pp |
| 2016 | 29.2% | €1.50 Million | €5.14 Million | €1.67 Million | €174.22K | ▲ +2.0 pp |
| 2015 | 27.1% | €1.40 Million | €5.15 Million | €1.54 Million | €142.00K | ▲ +11.0 pp |
| 2014 | 16.1% | €765.00K | €4.76 Million | €863.00K | €98.00K | ▼ -0.5 pp |
| 2013 | 16.6% | €783.00K | €4.72 Million | €847.00K | €64.00K | — |